These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24622844)

  • 1. Revisiting the TALE repeat.
    Deng D; Yan C; Wu J; Pan X; Yan N
    Protein Cell; 2014 Apr; 5(4):297-306. PubMed ID: 24622844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific DNA-RNA hybrid recognition by TAL effectors.
    Yin P; Deng D; Yan C; Pan X; Xi JJ; Yan N; Shi Y
    Cell Rep; 2012 Oct; 2(4):707-13. PubMed ID: 23022487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations of DNA-free and DNA-bound TAL effectors.
    Wan H; Hu JP; Li KS; Tian XH; Chang S
    PLoS One; 2013; 8(10):e76045. PubMed ID: 24130757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for sequence-specific recognition of DNA by TAL effectors.
    Deng D; Yan C; Pan X; Mahfouz M; Wang J; Zhu JK; Shi Y; Yan N
    Science; 2012 Feb; 335(6069):720-3. PubMed ID: 22223738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-RVD mutations that enhance the dynamics of the TAL repeat array along the superhelical axis improve TALEN genome editing efficacy.
    Tochio N; Umehara K; Uewaki JI; Flechsig H; Kondo M; Dewa T; Sakuma T; Yamamoto T; Saitoh T; Togashi Y; Tate SI
    Sci Rep; 2016 Nov; 6():37887. PubMed ID: 27883072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the TAL effector-DNA interaction.
    Bochtler M
    Biol Chem; 2012 Oct; 393(10):1055-66. PubMed ID: 23089535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of the Last Half Repeat in TAL Effectors Revealed by a Molecular Simulation Study.
    Wan H; Chang S; Hu JP; Tian XH; Wang MH
    Biomed Res Int; 2016; 2016():8036450. PubMed ID: 27803930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAL Effector DNA-Binding Principles and Specificity.
    Richter A; Streubel J; Boch J
    Methods Mol Biol; 2016; 1338():9-25. PubMed ID: 26443210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed evolution of the TALE N-terminal domain for recognition of all 5' bases.
    Lamb BM; Mercer AC; Barbas CF
    Nucleic Acids Res; 2013 Nov; 41(21):9779-85. PubMed ID: 23980031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat 1 of TAL effectors affects target specificity for the base at position zero.
    Schreiber T; Bonas U
    Nucleic Acids Res; 2014 Jun; 42(11):7160-9. PubMed ID: 24792160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAL effector specificity for base 0 of the DNA target is altered in a complex, effector- and assay-dependent manner by substitutions for the tryptophan in cryptic repeat -1.
    Doyle EL; Hummel AW; Demorest ZL; Starker CG; Voytas DF; Bradley P; Bogdanove AJ
    PLoS One; 2013; 8(12):e82120. PubMed ID: 24312634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
    Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
    PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-binding proteins from marine bacteria expand the known sequence diversity of TALE-like repeats.
    de Lange O; Wolf C; Thiel P; Krüger J; Kleusch C; Kohlbacher O; Lahaye T
    Nucleic Acids Res; 2015 Nov; 43(20):10065-80. PubMed ID: 26481363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the sequence diversity of TALE-like repeats to vary the strength of dTALE-promoter interactions.
    de Lange O; Schandry N; Wunderlich M; Berendzen KW; Lahaye T
    Synth Biol (Oxf); 2017 Jan; 2(1):ysx004. PubMed ID: 32995505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creating a TALE protein with unbiased 5'-T binding.
    Tsuji S; Futaki S; Imanishi M
    Biochem Biophys Res Commun; 2013 Nov; 441(1):262-5. PubMed ID: 24148249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TAL effector repeat architecture for frameshift binding.
    Richter A; Streubel J; Blücher C; Szurek B; Reschke M; Grau J; Boch J
    Nat Commun; 2014 Mar; 5():3447. PubMed ID: 24614980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
    Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational elasticity can facilitate TALE-DNA recognition.
    Lei H; Sun J; Baldwin EP; Segal DJ; Duan Y
    Adv Protein Chem Struct Biol; 2014; 94():347-64. PubMed ID: 24629191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
    de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
    Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.